<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> is characterized by a partial deficit of paired autosomal chromosome 15, which contains a subunit of the <z:chebi fb="3" ids="16865">GABA</z:chebi> (Gamma-Amino <z:chebi fb="4" ids="30772">Butyric Acid</z:chebi>) receptor </plain></SENT>
<SENT sid="1" pm="."><plain>Many drugs that act on the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> (Central Nerve System) during anesthesia are believed to exert their effects via the <z:chebi fb="3" ids="16865">GABA</z:chebi> receptors </plain></SENT>
<SENT sid="2" pm="."><plain>We describe the anesthesia of a 7 year-old female patient with <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> who underwent surgery for <z:hpo ids='HP_0000670'>dental caries</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The basic factors that needed to be considered when administering anesthesia to this patient were <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e>, significant dominance of the vagal tone, craniofacial abnormalities and peripheral <z:hpo ids='HP_0003202'>muscular atrophy</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Inhalational <z:chebi fb="37" ids="38867">anesthetics</z:chebi> (<z:chebi fb="0" ids="9130">sevoflurane</z:chebi>) were employed for this patient </plain></SENT>
<SENT sid="5" pm="."><plain>The patient had an uneventful peri-operative period and was discharged home on the same day of the operation </plain></SENT>
</text></document>